A Comparison of Radiation and Alkylator-Based Conditioning Therapy Regimens for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Clinician's Perspective.

Alejandro Marinos Velarde, Julio Alvarenga Thiebaud, Yazan Madanat, Amir Toor

Abstract readComparative StudyReview

In one paragraph

Review in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alejandro Marinos VelardeDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Julio Alvarenga ThiebaudDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Yazan MadanatDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-9573-2690

Amir ToorDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant advancements in the treatment of acute myeloid leukemia (AML), hematopoietic stem cell transplantation (HSCT) remains the only curative option for patients with primary refractory AML, those with relapsed disease and for patients who are in first complete remission where the disease has high risk cytogenetic and/or molecular features that increase relapse risk [...].

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteTransplantation ConditioningHumansTransplantation, Homologousacute myeloid leukemiaallogeneic stem cell transplantationconditioningmyeloablativereduced intensity conditioning

Identifiers

PMID40710192

DOI10.3390/curroncol32070381

PMCPMC12293537

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.